Vitamin D3 supplementation (4000 IU/d for 1 y) eliminates differences in circulating 25-hydroxyvitamin D between African American and white men

American Journal of Clinical Nutrition

Volumn 96, Issue 2, 2012, Pages 332-336

  Garrett Mayer, Elizabeth ^a   Wagner, Carol L ^a   Hollis, Bruce W ^a   Kindy, Mark S ^a,b   Gattoni Celli, Sebastiano ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; COLECALCIFEROL; 25-HYDROXYVITAMIN D; DRUG DERIVATIVE; VITAMIN D;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CANCER PATIENT; CAUCASIAN; CLINICAL TRIAL; DIET SUPPLEMENTATION; DRUG EFFECT; DRUG INDICATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PROSTATE CANCER; RACE DIFFERENCE; TREATMENT DURATION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; BODY MASS; COMPARATIVE STUDY; DOSE RESPONSE; ETHNOLOGY; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY;

AFRICAN AMERICANS; AGED; BODY MASS INDEX; CHOLECALCIFEROL; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; MALE; MIDDLE AGED; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84864349645     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.112.034256     Document Type: Article

References (34)

1. MacLaughlin JA, Holick MF. Biochemistry and physiology of the skin. In: Goldsmith LA, ed. Photobiology of vitamin D3 in the skin. New York, NY: Oxford University Press, 1983:734-54.
2. Esvelt RP, Schnoes HK, Deluca HF. Vitamin D3 from rat skins irradiated in vitro with ultraviolet light. Arch Biochem Biophys 1978;188: 282-6. (Pubitemid 8371779)
3. Matsuoka LY, Wortsman J, Haddad JG, Kolm P, Hollis BW. Racial pigmentation and the cutaneous synthesis of vitamin D. Arch Dermatol 1991;127:536-8.
4. Clemens T, Henderson SL, Adams J, Holick MF. Increased skin pigment reduces the capacity of skin to synthesise vitamin D3. Lancet 1982;9:74-6. (Pubitemid 12248649)
5. Ginde AA, Liu MC, Camargo CA. Demographic differences and trends of vitamin D insufficiency in the US population. Arch Intern Med 2009;169:626-32.
6. Nesby-O'Dell S, Scanlon K, Cogswell M, Gillespie C, Hollis B, Looker A, Allen C, Doughertly C, Gunter E, Bowman B. Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: Third National Health and Nutrition Examination Survey: 1988-1994. Am J Clin Nutr 2002;76: 187-92. (Pubitemid 34686565)
7. Bischoff-Ferrari HA, Dietrich T, Orav E, Dawson-Hughes B. Positive association between 25(OH)D levels and bone mineral density: a population-based study of younger and older adults. Am J Med 2004;116: 634-9. (Pubitemid 38490539)
8. Meier C, Woitge H, Witte K, Lemmer B, Seibel M. Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial. J Bone Miner Res 2004;19:1221-30.
9. Hollis BW. Circulating 25-hydroxyvitamin D levels indicative of vitamin sufficiency: Implications for establishing a new effective DRI for vitamin D. J Nutr 2005;135:317-22. (Pubitemid 40194499)
10. Haddock L, Corcino J, Vazquez MD. 25(OH)D serum levels in the normal Puerto Rican population and in subjects with tropical sprue and parathyroid disease. P R Health Sci J 1982;1:85-91.
11. Matsuoka LY, Wortsman J, Hanifan N, Holick MF. Chronic sunscreen use decreases circulating concentrations of 25-hydroxyvitamin D: a preliminary study. Arch Dermatol 1988;124:1802-4. (Pubitemid 19010098)
12. Feldman D, Glorieux FH, Pike JW. Vitamin D. Amsterdam, Netherlands: Elsevier Academic Press, 2005.
13. Parker J, Hashmi O, Dutton D, Mavrodaris A, Stranges S, Kandala NB, Clarke A, Franco OH. Levels of vitamin D and cardiometabolic disorders: systematic review and meta-analysis. Maturitas 2010;65:225-36.
14. Pearcy JN, Keppel K. A summary measure of health disparity. Public Health Rep 2002;117:273-80. (Pubitemid 35351236)
15. Mensah GA, Mokdad AH, Ford ES, Greenlund KJ, Croft JB. State of disparities in cardiovascular health in the United States. Circulation 2005;111:1233-41. (Pubitemid 40389086)
16. Lips P, Wiersinga A, Van Ginkel FC, Jongen MJ, Netelenbos JC, Hackeng WH, Delmas PD, Van der Vijgh WJ. The effect of vitamin D supplementation on vitamin D status and parathyroid function in elderly subjects. J Clin Endocrinol Metab 1988;67:644-50.
17. Lips P, Graafmans WC, Ooms ME, Bezemer PD, Bouter LM. Vitamin D supplementation and fracture incidence in elderly persons: a randomized, placebo-controlled clinical trial. Ann Intern Med 1996;124:400-6. (Pubitemid 26065071)
18. Sorya A, Risteli J, Risteli L, Valimaki M, Tilvis R. Effects of vitamin D and calcium on markers of bone metabolism in gastric patients with low serum 25(OH)D levels. Calcif Tissue Int 1991;49:588-9.
19. Vieth R, Chan PCR, MacFarlane GD. Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level (LOAEL). Am J Clin Nutr 2001;73:288-94. (Pubitemid 32109858)
20. Looker AC, Pfeiffer CM, Lacher DA, Schleicher RL, Picciano MF, Yetley EA. Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004. Am J Clin Nutr 2008;88:1519-27.
21. 3 supplementation in blachk youth: 25-hydroxyvitamin D, adiposity, and arterial stiffness. J Clin Endocrinol Metab 2010;95:4584-91.
22. The R Project for Statistical Computing. Homepage. Available from: http://www.r-project.org (cited 15 May 2012).
23. The BUGS Project. Homepage. Available from: http://www.mrc-bsu. cam.ac.uk/bugs (cited 15 May 2012).
24. Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ. Human serum 25-hydroxycholecaciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 2003;77:204-10. (Pubitemid 36015393)
25. Heaney RP, Armas LA, Shary JR, Bell NH, Binkley N, Hollis BW. 25-Hydroxylation of vitamin D3: relation to circulating vitamin D3 under various input conditions. Am J Clin Nutr 2008;87:1738-42. (Pubitemid 351872637)
26. Hollis BW, Johnson D, Hulsey TC, Ebeling M, Wagner CL. Vitamin D supplementation during pregnancy: double blind, randomized clinical trial of safety and effectiveness. J Bone Miner Res 2011;26:2341-57.
27. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2011;96:1911-30.
28. Institute of Medicine. Dietary Reference Intakes for calcium and vitamin D. Washington, DC: National Academy Press, 2011.
29. Ross AC, Manson JA, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, et al. The 2011 report on Dietary Reference Intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 2011;96:53-8.
30. Marshall DT, Savage SJ, Garrett-Mayer E, Keane TE, Hollis BW, Horst RL, Ambrose LH, Kindy MS, Gattoni-Celli S. Vitamin D3 supplementation at 4,000 IU per day for one year results in a decrease of positive cores at repeat biopsy in subjects with low-risk prostate cancer under active surveillance. J Clin Endocrinol Metab (Epub ahead of print 16 April 2012).
31. Mainous AG III, King DE, Garr DR, Pearson WS. Race, rural residence, and control of diabetes and hypertension. Ann Fam Med 2004;2: 563-8. (Pubitemid 39643431)
32. Holick MF. Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol 2009;19:73-8.
33. Artaza JN, Mehrotra R, Norris KC. Vitamin D and the cardiovascular system. Clin J Am Soc Nephrol 2009;4:1515-22.
34. Kuzawa CW, Sweet E. Epigenetics and the embodiment of race: developmental origins of US racial disparities in cardiovascular health. Am J Hum Biol 2009;21:2-15.